These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 21173136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
    Agarwal S, Bychkov A, Jung CK, Hirokawa M, Lai CR, Hong S, Kwon HJ, Rangdaeng S, Liu Z, Su P, Kakudo K, Jain D.
    Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
    [Abstract] [Full Text] [Related]

  • 3. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
    Wong KS, Jo VY, Lowe AC, Faquin WC, Renshaw AA, Shah AA, Roh MH, Stelow EB, Krane JF.
    Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
    [Abstract] [Full Text] [Related]

  • 4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

  • 5. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD, Pitman MB, Bloom L, Faquin WC.
    Cancer; 2006 Apr 25; 108(2):102-9. PubMed ID: 16453320
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of Hürthle cells in fine needle aspiration biopsy for multinodular goitre.
    Keskek M, Ocak S, Ozalp N, Koc M, Tez M.
    Endocr Regul; 2010 Apr 25; 44(2):65-8. PubMed ID: 20429635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z.
    Diagn Cytopathol; 2004 Nov 25; 31(5):307-12. PubMed ID: 15468114
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.
    Thyroid; 2013 Jun 25; 23(6):703-8. PubMed ID: 23544697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E, Holmes BJ, Krane JF, Nishino M, Zurakowski D, Hennessey JV, Faquin WC, Parangi S.
    Thyroid; 2015 Jul 25; 25(7):789-96. PubMed ID: 25962906
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
    Goldstein RE, Netterville JL, Burkey B, Johnson JE.
    Ann Surg; 2002 May 25; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.